Objectives: The chest wall arteriovenous graft (CWAVG) is becoming an alternative option for patients who have exhausted traditional upper extremity access, which used to be lower extremity arteriovenous grafts (LEAVG); however, which should be applied preferentially is unclear.
Objectives: No independent comparisons, with midterm follow-up, of standard (SAVG) and immediate-access arteriovenous grafts (IAAVGs)
Fig 2. The procedure diagram: A, Right axillary artery and vein were separated and suspended, respectively. B, The graft was end-to-side anastomosed to the axillary artery. A loop was constructed in a subcutaneous tunnel; an intermediate incision was made above the nipple. C, Another loop was constructed in a subcutaneous tunnel for end-to-side anastomosis to the axillary vein. The procedure diagram: A, The graft was end-to-side anastomosed to the left femoral artery and vein. A loop was constructed in a subcutaneous tunnel; an intermediate incision was made on the thigh. Hemodialysis access at 3 months after operation, showing good patency rate and visible puncture markers on line area. B, Another loop was constructed in a subcutaneous tunnel for end-to-side anastomosis to femoral artery and vein. C, The complications of lower extremity arteriovenous graft (LEAVG) include ischemia, even amputation, and infection and hematoma. exist. The goal of this study was to compare the real-world performance of SAVGs and IAAVGs.
Methods: Consecutive patients who underwent placement of an AVG for hemodialysis between November 2014 and April 2016 were retrospectively identified from the electronic medical record and Vascular Quality Initiative database at two tertiary centers. Only primary graft placements were included for analysis. Patients were divided into two groups based on the type of graft implanted (SAVG and IAAVG). Patient comorbidities, graft configuration, operative characteristics, and subsequent follow-up were collected and analyzed with respect to primary patency, primary assisted patency, and secondary patency. Additional outcomes included graft-related complications, time to first cannulation, time to tunneled catheter removal, catheter-related complications and overall survival. Patency was defined per Society for Vascular Surgery recommended reporting standards and was determined from the time of the index procedure. Analysis included c 2 , Kaplan-Meier, and Cox regression, with the P value <.05 set as significant.
Results: A total of 210 grafts met inclusion criteria, 148 SAVG and 62 IAAVG. At baseline, patient characteristics were similar between groups, except for a greater prevalence of preoperative central venous occlusions in the IAAVG group (16.3% vs 6.8%; P < .04). Of the IAAVG group, 50 were Acuseal (W. L. Gore) and 12 were Flixine (Maquet). Overall primary, primary assisted, and secondary patency were 43.8%, 45.3%, and 48.2% at 12 months and 28.0%, 29.8%, and 30.6% at 24 months. Overall survival was 48% at 24 months. Between the two groups, there were no significant differences in patency rates. Regression analysis did not show any association to the type of graft; however, IAAVG patients required fewer overall additional procedures to maintain patency (mean number of procedures: SAVG, 0.99; IAAVG, 0.61; P ¼ .025). There was no difference in occurrence of steal syndrome (SAVG, 11.8%; IAAVG, 20.0%; P ¼ .296) or graft infection (SAVG, 19.0%; IAAVG, 12.0%; P ¼ .276). Most grafts (75%) were successfully cannulated, with mean time to cannulation being shorter in the IAAVG group (42.1 6 32.7 days vs 13.4 6 18.3 days; P < .001). Most pre-existing catheters (65.75%) were removed, with mean catheter dwell time being shorter in the IAAVG group (59.3 6 37.1 days vs 35.7 6 26.7 days; P ¼ .004). Temporary dialysis catheter-related complications occurred less frequently in the IAAVG group (20.5% vs 2.9%; P < .045).
Conclusions: IAAVGs allow earlier cannulation and temporary dialysis catheter removal with fewer secondary procedures while having similar graft-related outcomes to SAVG.
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VS06. The RADAR Technique of Arteriovenous Fistula Creation
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Hybrid Fenestrated Repair of a Juxtarenal Aneurysm With Congenital Pelvic Kidney
Mathew Wooster, Martin Back. University of South Florida, Tampa, Fla
Objectives: Since its first description, fenestrated endovascular repairs for paravisceral abdominal aortic aneurysms have become widely popularized. The only currently commercially available device in the United States, however, remains the Cook Zenith Fenestrated device, which continues to have multiple anatomic restraints to its possible configurations. Beyond the average restraints, congenital visceral arterial anomalies can make endovascular repair particularly cumbersome. We present here such a case in which a patient with a congenital pelvic kidney not amenable to endovascular repair with a custom fenestrated device was able to be treated with one using preoperative surgical debranching.
Methods: A 65-year-old man was found to have a 5.5-cm pararenal aortic aneurysm complicated by a congenital left pelvic kidney with a normal anatomic configuration of his right kidney. Evaluation for open vs endovascular repair was significant for chronic obstructive pulmonary disease, severe coronary disease status postmultivessel bypass, and associated heart failure with ejection fraction <20%, with small areas of reversible ischemia and expected daily functional inhibition. Given his poor cardiac reserve, he was deemed too high risk for direct aortic repair with suprarenal or supraceliac cross-clamp unlikely to be tolerated, with a Vascular Quality Initiative risk score suggesting 15% risk of perioperative myocardial infarction. However, his variant renal artery anatomy precluded him from standard endovascular repair. Ultimately, he was offered debranching of his pelvic renal artery with interval custom Zenith fenestrated endograft repair.
Results: Renal artery debranching was performed via a midline incision to expose the distal aorta and right common iliac artery. A 6-mm heparin-bonded polytetrafluoroethylene conduit was used to create bypass from the right common iliac artery to the pelvic renal artery. Estimated blood loss was 400 mL, with an operative time of 2 hours. His recovery was uneventful, discharging home on postoperative day 5. He returned 8 weeks later for planned endovascular completion of his repair. A custom 32-Â 94-mm Zfen device with right renal fenestration and large superior mesenteric artery scallop was deployed. A 7-Â 22-mm iCAST renal stent and 9-Â 25-mm Express superior mesenteric artery stent completed the repair. Total fluoroscopy time was 29 minutes, with 95 mL of iodinated contrast usage. His postoperative course was again uneventful, and now 1 year out, has a stable aneurysm sac without endoleak and patent renal/mesenteric arteries by computed tomography angiogram and renal duplex ultrasound imaging.
Conclusions: Congenital pelvic kidney represents a unique anatomic limitation to aortic aneurysm repair. Creative combinations of open and endovascular therapy can be used to treat even high-medical-risk patients.
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Racial Disparities in Endovascular Aortic Aneurysm Repair
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Objectives: Racial and ethnic disparities are a critical issue in access to care within all fields of medicine. Techniques and devices for endovascular aortic aneurysm repair (EVAR) have improved significantly, allowing the safe, minimally invasive treatment of more complex anatomies by a wider array of practitioners. We hypothesized that analysis of a statewide
